Curaleaf Holdings (CURLF) Share-based Compensation (IS) (2019 - 2026)

Curaleaf Holdings (CURLF) recorded quarterly Share-based Compensation (IS) of $9.7 million in Q1 2026, down 6.12% quarter-over-quarter from $10.3 million in Q3 2025, and up 109.0% on a YoY basis from $4.6 million in Q1 2025.

Curaleaf Holdings (CURLF) Share-based Compensation (IS) (2019 - 2026) Analysis & Trends

Curaleaf Holdings' Share-based Compensation (IS) history runs 8 years deep, the most recent figure standing at $9.7 million for Q1 2026.

  • In Q1 2026, Share-based Compensation (IS) rose 109.0% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $33.1 million (up 32.27% YoY), while the FY2022 annual figure was $6.9 million, down 82.54% from the prior year.
  • Share-based Compensation (IS) was $9.7 million for Q1 2026 at Curaleaf Holdings, down from $10.3 million in the prior quarter.
  • In the past five years, Share-based Compensation (IS) ranged from a high of $10.3 million in Q3 2025 to a low of $4.6 million in Q1 2025.
  • Historically, Share-based Compensation (IS) has averaged $7.0 million across 5 years, with a median of $6.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Share-based Compensation (IS) plunged 60.58% in 2022, then jumped 109.0% in 2026.
  • A 5-year view of Share-based Compensation (IS) shows it stood at $6.9 million in 2022, then slipped by 9.72% to $6.2 million in 2023, then decreased by 3.29% to $6.0 million in 2024, then surged by 71.08% to $10.3 million in 2025, then retreated by 6.12% to $9.7 million in 2026.
  • The last three Share-based Compensation (IS) figures came in at $9.7 million (Q1 2026), $10.3 million (Q3 2025), and $8.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Curaleaf Holdings - - 157.29 Mn 9.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.66 Mn
Mar 31, 2026 9.66 Mn
Sep 30, 2025 10.29 Mn
Sep 30, 2025 10.29 Mn
Jun 30, 2025 8.48 Mn
Jun 30, 2025 8.48 Mn
Mar 31, 2025 4.62 Mn
Mar 31, 2025 4.62 Mn
Sep 30, 2024 6.02 Mn
Sep 30, 2024 6.02 Mn
Jun 30, 2024 6.84 Mn
Jun 30, 2024 6.84 Mn
Mar 31, 2024 7.51 Mn
Mar 31, 2024 7.51 Mn
Sep 30, 2023 6.22 Mn
Sep 30, 2023 6.22 Mn
Jun 30, 2023 6.25 Mn
Jun 30, 2023 6.25 Mn
Dec 31, 2022 6.89 Mn
Dec 31, 2022 6.89 Mn